Optimizing Prostate Intensity-Modulated Radiation Therapy (IMRT): Do Stricter Constraints Produce Better Dosimetric Results?

Author(s): Courtney R Buckey | Gregory P Swanson | Sotirios Stathakis | Nikos Papanikolaou
Volume: 2
Issue: 2
Year: 2010

Triapine in Clinical Practice

Author(s): Aisha B Miah | Kevin J Harrington | Chris M Nutting
Volume: 2
Issue: 2
Year: 2010

Thrombocytopenia in Solid Tumors

Author(s): Mustafa Khasraw | Heewa Faraj | Anwar Sheikha
Volume: 2
Issue: 2
Year: 2010

Secondary Causes of Low Bone Mineral Density in Breast Cancer Patients: An Update

Author(s): Y Chiu Kang | Julie A Miller | G Bruce Mann
Volume: 2
Issue: 2
Year: 2010

Treatment of Recurrent Platinum-Sensitive Epithelial Ovarian Cancer

Author(s): Joyce F Liu | Ursula A Matulonis
Volume: 2
Issue: 2
Year: 2010

Impact of Re-Surgery for Debulking in Incompletely Operated Advanced-Stage Ovarian Carcinoma Patients

Author(s): Murat Gultekin | Polat Dursun | Nejat Ozgul | Ali Ayhan
Volume: 2
Issue: 2
Year: 2010

Gene Expression Profiling of Gastrointestinal Stromal Tumor: Implications for Clinical Management

Author(s): Umio Yamaguchi | Kazufumi Honda | Tesshi Yamada
Volume: 2
Issue: 2
Year: 2010

Adjuvant Cisplatin-Based Chemotherapy for Elderly Patients with Completely Resected Non-Small Cell Lung Cancer: Review of Current Evidence

Author(s): Martin Fruh | Frances A Shepherd
Volume: 2
Issue: 2
Year: 2010

Prognostic Value of Minimal Residual Disease Monitoring in the Context of Allogeneic Stem Cell Transplantation in Childhood Acute Lymphoblastic Leukemia

Author(s): Andre Willasch | Hermann Kreyenberg | Thomas Klingebiel | Peter Bader
Volume: 2
Issue: 2
Year: 2010

Treating Locally Advanced, Recurrent or Metastatic Endometrial Cancer: A Focus on Ixabepilone

Author(s): Kimberly Kilfoyle | Don S Dizon
Volume: 2
Issue: 2
Year: 2010

Lung Cancer Incidence in Never Smokers

Author(s): Christelle Clément-Duchêne | Heather Wakelee
Volume: 2
Issue: 2
Year: 2010

The Prevalence of Lymphedema and Changes in Practice to Reduce its Occurrence in Women with Breast Cancer

Author(s): Sarah A McLaughlin | Kimberly J Van Zee
Volume: 2
Issue: 2
Year: 2010

Autologous Stem Cell Transplantation as First-Line Therapy in Peripheral T-Cell Lymphomas

Author(s): Peter Reimer
Volume: 2
Issue: 2
Year: 2010

Breast Intensity-Modulated Radiation Therapy to Reduce Radiation Dermatitis

Author(s): Jean-Philippe Pignol | Ivo Olivotto
Volume: 2
Issue: 2
Year: 2010

Novel Strategies for Diagnosis of Glioblastoma Multiforme

Author(s): Adam M Sonabend | Jonathan Yun | Peter Canoll | Jeffrey N Bruce
Volume: 2
Issue: 2
Year: 2010

Future Role of HER-2/neu Vaccines in the Treatment of Breast Cancer

Author(s): Nicole E Bates | Mary L Disis
Volume: 2
Issue: 2
Year: 2010

Pancreatic Neuroendocrine Tumors: A Focus on the Current Classification and Molecular Targeted Therapy

Author(s): Michela Squadroni | Vincenzo Formica | Giovanni Di Meglio | Cristina Dealis | Francesca Spada | Katia Lorizzo | Nicola Fazio
Volume: 2
Issue: 2
Year: 2010

Genes Discriminating between Breast Cancers Responsive or Resistant to the Aromatase Inhibitor, Letrozole

Author(s): William R Miller | Andreas Krause | Alexey Larionov | Dean B Evans | Thomas J Anderson | J Michael Dixon
Volume: 2
Issue: 2
Year: 2010

Analysis of Adjuvant Chemotherapy in Non-Small Cell Lung Cancer

Author(s): Sinead Cuffe | Natasha B Leighl
Volume: 2
Issue: 2
Year: 2010

Treatment Strategies for Relapsed or Refractory Peripheral T-cell Lymphomas

Author(s): Seok Jin Kim | Won Seog Kim
Volume: 2
Issue: 1
Year: 2010

ALK-Positive Diffuse Large B-cell Lymphoma: An Aggressive Clinicopathological Entity

Author(s): Brady Beltran | Eric S Winer | Jorge Castillo
Volume: 2
Issue: 1
Year: 2010

Vitamin D Deficiency in Multiple Myeloma

Author(s): Matthew T Drake | Alvin C Ng
Volume: 2
Issue: 1
Year: 2010

Integrins – a Relevant Target in Glioblastoma

Author(s): Xiaosi Han | L B Nabors
Volume: 2
Issue: 1
Year: 2010

Trabectedin: An Emerging Therapeutic Option in Soft Tissue Sarcoma

Author(s): Jean-Yves Blay
Volume: 2
Issue: 1
Year: 2010

Targeting Angiogenesis in Non-Small Cell Lung Cancer: Agents in Practice and Clinical Development

Author(s): Afsaneh Barzi | Nathan A Pennell
Volume: 2
Issue: 1
Year: 2010

Management of Infectious Complications in Chronic Lymphocytic Leukemia

Author(s): Estella Matutes
Volume: 2
Issue: 1
Year: 2010

Intravenous Bisphosphonates for Preventing Bone Loss in Allogeneic Stem Cell Recipients

Author(s): Sang Kyun Sohn
Volume: 2
Issue: 1
Year: 2010

Adjuvant Radiotherapy and Chemotherapy for Resected Pancreatic Adenocarcinoma: Review of Current Evidence

Author(s): Michelle A Neben-Wittich | Michael C Stauder | Fernando Quevedo | Michele M Corsini | Matthew J Iott | Robert C Miller
Volume: 2
Issue: 1
Year: 2010

Severe Skin Lesions in Patients with Glioblastoma Multiforme Treated with a Combination of Cetuximab, Bevacizumab, and Irinotecan

Author(s): Morten Sorensen | Tine Bernhardtsen Gaziel | Benedikte Hasselbalch | Hans Skovgaard Poulsen | Ulrik Lassen
Volume: 2
Issue: 1
Year: 2010

Circulating Tumor Cells: A Potential Bladder Cancer Biomarker?

Author(s): David J Gallagher | Matthew I Milowsky
Volume: 2
Issue: 1
Year: 2010

Acute Myeloid Leukemia after Breast Cancer: Therapy Related or Host Associated?

Author(s): Geoffrey F Beadle | Alessandra Francesconi | Peter Baade
Volume: 2
Issue: 1
Year: 2010

Docetaxel and Irinotecan Combination Chemotherapy in Advanced Esophageal Cancer

Author(s): Satish Shanbhag | Barbara Burtness
Volume: 2
Issue: 1
Year: 2010

Central Nervous System Involvement in Mantle Cell Lymphoma

Author(s): Ana Ferrer | Armando López-Guillermo
Volume: 2
Issue: 1
Year: 2010

Treating the Anemic Oncology Patient with Intravenous Iron: Why, When, and How?

Author(s): Smeeta Sinha | Philip A Kalra
Volume: 2
Issue: 1
Year: 2010

The Role of Portal Vein Embolization Prior to Hepatic Resection for Primary and Secondary Hepatic Malignancies

Author(s): Shaun Mckenzie | Joseph Kim
Volume: 2
Issue: 1
Year: 2010

The Evolving Role of 18F-FDG PET Scans in Patients with Aggressive non-Hodgkin's Lymphoma

Author(s): Peter J Hosein | Izidore S Lossos
Volume: 2
Issue: 1
Year: 2010

Anti-Angiogenesis Therapy in the Treatment of Non-Small Cell Lung Cancer: The Role of Monoclonal Antibodies and Multitargeted Tyrosine Kinase Inhibitors

Author(s): Thomas E Stinchcombe
Volume: 2
Issue: 1
Year: 2010

Predictive Markers for Chemotherapy Toxicity: an Important Factor in Personalized Therapy

Author(s): Junichi Matsubara | Masaya Ono | Tesshi Yamada
Volume: 2
Issue: 1
Year: 2010

Familial Aspects of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and Related Lymphomas

Author(s): Lynn R Goldin | Ola Landgren | Gerald E Marti | Neil E Caporaso
Volume: 2
Issue: 1
Year: 2010

Comprehensive Meta-Analysis of Survival Outcomes from Two Randomized Multicenter Trials in First-Line Advanced Non-Small Cell Lung Cancer in Patients Treated with the Novel Investigational Antitumor-enhancing and Chemoprotective Agent Tavocept

Author(s): Frederick Hausheer | Stacey Bain | Michael Perry | Lingu Du | Yasuo Ohashi | Yutaka Ariyoshi | Masahiro Fukuoka
Volume: 2
Issue: 1
Year: 2010

Chemotherapy in Head and Neck Cancers: Summary of Recommendations and a Critical Review of Clinical Practice Guidelines

Author(s): Weng Ng | Susannah Jacob | Geoff Delaney | Michael Barton
Volume: 2
Issue: 1
Year: 2010

Unmet Medical Needs in Glioblastoma Management and Optimal Sequencing of the Emerging Treatment Options

Author(s): Oliver Schnell | Jörg-Christian Tonn
Volume: 2
Issue: 1
Year: 2010

ProGRP: A New Biomarker for Small Cell Lung Cancer

Author(s): Rafael Molina
Volume: 2
Issue: 1
Year: 2010